FRK and non-small cell lung carcinoma: (2020) evaluated the possible effect of the genetic depletion of Fyn-related kinase (FRK) by CRISPR/Cas9 in lung carcinoma H1299 cells to elucidate its role in NSCLC pathogenesis [171].